EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January–April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status

Evelyne Huyghe iD, Steven Abrams, Emmanuel André, Kurt Anseeuw, Eva Bernaert, Peggy Bruynseels, Lize Cuypers, Pieter De Schouwer, Petra Hilkens, Els Keyaerts, Lies Laenen, Justine Maes und 6 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Evelyne Huyghe und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ziekenhuis aan de Stroom, Antwerp, Belgium. Hauptthemen laut MEDLINE: Influenza, Human, Viral Load, COVID-19, Influenza B virus. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three hospitals implemented molecular point‐of‐care tests (POCTs) to screen patients for SARS‐CoV‐2 infection upon admission during the 2021/2022 influenza season, which in Belgium lasted from January to April 2022. The samples were simultaneously tested for influenza A/B. Influenza positivity at admission was examined in relation to patient characteristics and symptomatology. Influenza POCTs were performed on all patients requiring urgent hospitalization, regardless of the admission reason. A total of 9327 patients were included in the study, of which 411 (4.4%) tested positive for influenza A/B. Asymptomatic infection and mild illness accounted for respectively 11.2% (95% CI: 8.5%–14.6%), and 43.3% (95% CI: 38.6%–48.1%) of the cases. A total of 66% (95% CI: 60%–72%) of all patients in these symptom categories (asymptomatic and mild illness) showed a high viral load (cycle threshold [Ct] < 24). Only in 30 (7.3%, 95% CI: 5.2%–10.2%) of all cases and in two (4.4%, 95% CI: 1.2%–14.5%) of the asymptomatic cases, the symptomatology worsened during hospital stay. Coinfections with both influenza and SARS‐CoV‐2 occurred in 35 patients (8.5% of all influenza positive patients). There was no difference in symptomatology between patients with co‐infections and those with an influenza mono‐infection. Patients could not be reliably categorized into carriers with low versus high viral loads based on symptomatology, age, and vaccination status. More than half of the influenza‐positive individuals were either asymptomatic or had mild symptoms upon admission, while often carrying high viral loads. Our results show that without screening of patients at hospital admission, a considerable number of patients with a high viral load may be incorrectly classified as being not infectious.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanViral LoadCOVID-19Influenza B virusInfluenza A virusHumansBelgiumMaleFemaleMiddle AgedAgedAdultHospitalizationSARS-CoV-2AdolescentYoung AdultVaccinationAged, 80 and overMass ScreeningChildChild, PreschoolPoint-of-Care TestingAge FactorsInfantInfluenza Vaccines

Stichwörter der Autor:innen

LIATPOCTepidemiologyinfluenza

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Ziekenhuis aan de Stroom, Antwerp, Belgium.
  • Department of Infection Prevention and Control, Ziekenhuis aan de Stroom, Antwerp, Belgium.
  • Data Science Institute, Interuniversity Institute for Biostatistics and statistical Bioinformatics, UHasselt, Diepenbeek, Belgium.
  • Global Health Institute, Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.
  • Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium.
  • Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, Leuven, Belgium.

ORCID-Profile: Evelyne Huyghe

Zitieren

APA

Huyghe, E., Abrams, S., André, E., Anseeuw, K., Bernaert, E., Bruynseels, P., Cuypers, L., De Schouwer, P., Hilkens, P., Keyaerts, E., Laenen, L., Maes, J., Magerman, K., Van de Gaer, O., Verdonck, A., Verstrepen, W., Ombelet, S., & Naesens, R. (2025). Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January–April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status. Journal of Medical Virology. https://doi.org/10.1002/jmv.70167

Vancouver

Huyghe E, Abrams S, André E, Anseeuw K, Bernaert E, Bruynseels P, et al. Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January–April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status. Journal of Medical Virology. 2025. doi:10.1002/jmv.70167

BibTeX
@article{Huyghe2025,
  author = {Huyghe, Evelyne and Abrams, Steven and André, Emmanuel and Anseeuw, Kurt and Bernaert, Eva and Bruynseels, Peggy and Cuypers, Lize and De Schouwer, Pieter and Hilkens, Petra and Keyaerts, Els and Laenen, Lies and Maes, Justine and Magerman, Koen and Van de Gaer, Otto and Verdonck, Ann and Verstrepen, Walter and Ombelet, Sien and Naesens, Reinout},
  title = {Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January–April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70167}
}
Kostenlos starten →